CANDESARTAN HCT Zentiva cpr 8/12.5 mg 30 pce
7680623210135
CH-62321
C09DA06
02.07.2.
Active substances:
1 / 3
google
Details
- Product number
- 6232101
- CPT
- -
- Packaging group
- 30
- Unit
- Tablette(n)
- Composition
- candesartanum cilexetilum 8 mg, hydrochlorothiazidum 12.5 mg, maydis amylum, lactosum monohydricum 117.3 mg, triethylis citras, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium 0.36 mg, magnesii stearas, pro compresso.
Articles (1)
Candesartan HCT Zentiva 8/12.5mg, Tabletten
Tabletten
30
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
candesartanum cilexetilum
|
8.0 MG | Substance | Wirkstoff (Principe actif) |
|
hydrochlorothiazidum
|
12.5 MG | Substance | Wirkstoff (Principe actif) |
|
maydis amylum
|
- | Substance | HNIDK |
|
lactosum monohydricum
|
117.3 MG | Substance | HBESI |
|
triethylis citras
|
- | Substance | HNIDK |
|
hydroxypropylcellulosum
|
- | Substance | HNIDK |
|
carmellosum natricum conexum
|
- | Substance | HNIDK |
|
natrium
|
0.36 MG | Substance | HBESI |
|
magnesii stearas
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 16.50
Specialties list
Yes
Generic
Yes
SL addition date:
01/09/2012
Authorization holder
Helvepharm AG
8500 Frauenfeld
Authorization information
- Swissmedic authorization number
- 62321
- Drug name
- Candesartan HCT Zentiva, Tabletten
- Galenic form
- TAB
- ATC Code
- C09DA06
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 30/01/2012
- Authorization expiration date
- 31/12/9999
- IT number
- 02.07.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- CANDESARTAN HCT Zentiva cpr 8/12.5 mg 30 pce
- Description (DE)
- CANDESARTAN HCT Zentiva Tabl 8/12.5 mg 30 Stk
- Market launch
- 30/01/2012
- Narcotic (BTM)
- No